[Pulmonary aspergillosis in the neutropenic patient. Apropos of 4 cases].
Ben Othman
T
T
Service d'hématologie, Hôpital Aziza Othmana, Tunis.
Ben Lakhal
B
B
Medini Manai
Z
Z
Ladeb
S
S
M'Sadek
F
F
Meddeb
B
B
Ben Abid
H
H
Bel Hadj Ali
Z
Z
Hafsia
R
R
Ben Abdeladhim
A
A
Hafsia
A
A
D000293:Adolescent; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D004352:Drug Resistance, Microbial; D017809:Fatal Outcome; D006801:Humans; D016867:Immunocompromised Host; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy; D008172:Lung Diseases, Fungal / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy
D000935:Antifungal Agents; D000666:Amphotericin B
Aspergillose pulmonaire du sujet neutropenique. A propos de 4 cas.